Clinical Trial Update: Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and immunogenicity of a Clostridium difficile toxoid vaccine in healthy adults, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Clostridium difficile toxoid vaccine (Clostridium difficile toxoid vaccine)

Snippet

Sponsor: Sanofi | Conditions: Clostridium Infections | Phase 1 | Status: COMPLETED | Results posted: 2012-05-21